John Rascco
An executive at General Motors and a prominent entrepreneur of the 1920s, described as the 'Elon Musk of his era'. He advocated for the 'ordinary investor' and attempted to create an early version of a mutual fund.
First Mentioned
10/17/2025, 4:48:34 AM
Last Updated
10/17/2025, 4:52:05 AM
Research Retrieved
10/17/2025, 4:52:05 AM
Summary
While the entity name provided was "John Rascco," the most relevant information from web search results pertains to "John E. J. Rasko," an Australian clinical hematologist, pathologist, and scientist. Rasko is recognized for his extensive research in gene and stem cell therapy and his leadership roles in various medical and scientific organizations, including directing departments at Royal Prince Alfred Hospital and the Centenary Institute. He is also a notable science communicator, having delivered the ABC's 2018 Boyer Lectures, "Life Re-engineered," which explored the history and impact of gene and cell therapies.
Referenced in 1 Document
Research Data
Extracted Attributes
Role
Science communicator
Full Name
John E. J. Rasko
Birth Year
1961 (citation needed)
Profession
Clinical hematologist, pathologist, scientist
Nationality
Australian
Notable Work
ABC's 2018 Boyer Lectures, 'Life Re-engineered'
Research Focus
Gene and stem cell therapy, experimental haematology, molecular biology
Discrepancy Note
Information is for 'John E. J. Rasko', not 'John Rascco', due to high relevance in web search results.
Timeline
- Born (citation needed). (Source: Wikipedia)
1961
- Co-founded the Australasian Gene and Cell Therapy Society (AGCTS). (Source: Wikipedia)
2000
- Served as past-President of the Australasian Gene and Cell Therapy Society (AGCTS). (Source: Wikipedia)
2003-2005
- Began serving as Chair of the Gene Technology Technical Advisory Committee (GTTAC), Office of the Gene Technology Regulator. (Source: Wikipedia)
2008
- Served as Vice President of the International Society for Cellular Therapy (ISCT). (Source: Wikipedia)
2008-2012
- Chaired the Advisory Committee on Biologicals, Therapeutic Goods Administration. (Source: Wikipedia)
2012-2015
- Delivered the ABC's Boyer Lectures, titled 'Life Re-engineered', examining the history and impact of gene and cell therapies. (Source: Wikipedia)
2018
- Served as President of the International Society for Cellular Therapy (ISCT). (Source: Wikipedia)
2018-2020
Web Search Results
- John E. J. Rasko - Wikipedia
John E. J. Rasko (born 1961[citation needed]) is an Australian clinical hematologist, pathologist and scientist whose research focuses on gene and stem cell therapy, experimental haematology and molecular biology. He previously directed the Department of Cell and Molecular Therapies at Royal Prince Alfred Hospital, the Gene and Stem Cell Therapy Program at the Centenary Institute, Sydney, and Sydney Medical School, the University of Sydney. He is a science communicator, often interviewed on [...] Australian radio and television, and is a regular contributor to Breakfast, Radio National, ABC. Rasko delivered the ABC's 2018 Boyer Lectures. Entitled Life Re-engineered, they examined the history and impact of gene and cell therapies. [...] Rasko is Chair of the Gene Technology Technical Advisory Committee (GTTAC), Office of the Gene Technology Regulator (2008–), and Chaired the Advisory Committee on Biologicals, Therapeutic Goods Administration (2012–15). Contributions to scientific organisations include co-founder (2000) and past-President (2003–05) of the Australasian Gene and Cell Therapy Society (AGCTS); Vice President (2008–12), and President (2018–20), International Society for Cellular Therapy (ISCT), and founder (2009) of
- John Resko - Biography - IMDb
John Resko was born on February 16, 1911 in New York, New York, USA. He was a writer, known for Convicts 4 (1962), The Alfred Hitchcock Hour (1962) and Here's
- Businessman gets 8 years in prison for theft of COVID funds | AP News
A federal investigation found John Trasacco, 50, had conspired with former state Rep. Michael DiMassa to submit fraudulent invoices from two
- Read News and Stories about John Rasko - Oncodaily
Where to study to become an ESMO President: 2025 Top Institutional Rankings Where to study to become an ESMO President: 2025 Top Institutional Rankings # John Rasko John Rasko: Exceptional Contributions to Global Medicine and to Healthcare Reform in China john rasko ### Headlines Findings from the Global Cancer Movement – Challenging the Status Quo in Colorectal Cancer Congress published in OncoDaily Medical Journal Google Cloud, Color Health Debut AI Agent To Fast-Track Mammograms [...] Phone number: +1 978 717 48 84 Email: (/cdn-cgi/l/email-protection#20494e464f604f4e434f4441494c590e434f4d) #### OncoDaily #### Oncology #### cancer #### fight against cancer #### Global fight against cancer #### Breast Cancer #### cancer care #### ASCO #### Lung cancer #### Cancer research #### MD Anderson Cancer Center #### NSCLC #### cancer awareness #### ESMO #### immunotherapy #### cancer treatment #### Research #### Headlines #### ASCO24 #### Childhood Cancer [...] #### colorectal cancer #### prostate cancer #### AACR #### clinical trials #### FDA #### Dana-Farber Cancer Institute #### UICC #### European Cancer Organisation #### American Cancer Society #### NCI #### National Cancer Institute #### SIOP #### chemotherapy #### healthcare #### Vivek Subbiah #### ASCO25 #### American Society of Clinical Oncology #### AI #### Paolo Tarantino #### Robert Orlowski #### IASLC #### radiation oncology #### WHO #### Myeloma Paper of the Day
- Visa, Mastercard agree to $199.5 million settlement in merchants ...
The case is B&R Supermarket Inc et al v. Visa Inc et al, U.S. District Court, Eastern District of New York, No. 1:17-cv-02738-MKB-JAM. For plaintiffs: George Aguilar and Michael Nicoud of Robbins; John Devine of Devine Goodman & Rasco; and Thomas Amon of Law Office of Thomas G. Amon For Visa: Matthew Eisenstein and Robert Vizas of Arnold & Porter Kaye Scholer For Mastercard: Kenneth Gallo and Brette Tannenbaum of Paul, Weiss, Rifkind, Wharton & Garrison Read more: [...] BusinesscategoryJPMorgan to invest up to $10 billion in US national security as part of $1.5 trillion pledge LitigationcategoryData company Agri Stats settles poultry worker wage-fixing lawsuit SustainabilitycategoryGoldman Sachs loses senior bankers after leadership reshuffles, dealmaking pause LitigationcategorySpirit Airlines cancels Airbus order in settlement with AerCap GovernmentcategoryUS SEC says India yet to serve summons to Adani executives in bribery indictment [...] Legal IndustrycategoryGold Reserve moves to disqualify judge, advisers in Citgo parent auction World at WorkcategoryNASA's Jet Propulsion Laboratory to lay off about 550 workers TransactionalcategoryGoldman Sachs buys venture capital firm Industry Ventures SustainabilitycategoryGerman authorities nix 1,400 websites used for cybertrading fraud SustainabilitycategoryStarboard Value takes stake in Keurig Dr Pepper amid JDE Peet's buyout